Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 2Thoracic 1CNS 1

Conditions

Thromboembolism 1Respiratory Insufficiency 1Pneumonia 1Myocardial Infarction 1Lung Neoplasms 1Arrhythmias, Cardiac 1Angina, Unstable 1Acute Coronary Syndrome 1

Interventions

Carboplatin 510Cisplatin 410Pemetrexed 400Radiotherapy 285Docetaxel 244Paclitaxel 227pembrolizumab 226Gemcitabine 198Drug Therapy 191Bevacizumab 190Erlotinib Hydrochloride 189Radiosurgery 177Nivolumab 168Etoposide 155durvalumab 154osimertinib 126atezolizumab 109Gefitinib 96Blood Specimen Collection 93Magnetic Resonance Spectroscopy 91Vinorelbine 90anlotinib 88Surgical Procedures, Operative 85Ipilimumab 62Immunotherapy 62Surveys and Questionnaires 60sintilimab 59Specimen Handling 59tislelizumab 58Irinotecan 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Fluoridation × Thoracic × Clear all
NCT01370278 2023-08-25

Clearance Of Mucus In Stents (COMIS)

M.D. Anderson Cancer Center

Phase NA Completed
43 enrolled
Thoracic

Angina, Unstable, Arrhythmias, Cardiac, Lung Neoplasms, Myocardial Infarction, Pneumonia, Respiratory Insufficiency, Thromboembolism, Acute Coronary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡